Animal Health Market

Drivers:

Increasing incidences of Zoonotic disease and increasing development of e-commerce platforms have promoted virtual shops and health care services for animals. Several non-profit organizations have come forward in recent times in educating the public about care to be given to animals. This factor has increased the overall growth of the animal health market in recent times.

The increasing popularity of online stores, easy availability, and discounted products are the major reasons for the increasing demand for pet-related stuff. The key market players and emerging market players in recent times are willing to increase their investment for the R&D development in the market. The first honeybee vaccine in the world is being developed by the College of Agricultural and Environmental Sciences at the University of Georgia in collaboration with Dalan Animal Health. 

The American Foulbrood (AFB) disease, formerly one of the most destructive pest illnesses of the honeybee breed, will be prevented by this vaccination. The viability of the entire colony is clearly at stake from the disease known as AFB. There is no cure for it once it has infected a colony. Beekeepers in Georgia and numerous other states are required to burn AFB-infected hives.

Opportunities:

Increasing government initiatives in countries such as Europe, US is presenting lucrative opportunities for the overall growth of the animal health market. The AWBI stands for Animal Welfare Board of India, organizes and administrates various sectors of animal welfare such as fisheries, animal husbandry, dairying, and other sectors. The primary aim of the AWBI is to provide proper financial support for the animal farms and offer proper maintenance of sheltered animals and rescued cattle. Such factors are stimulating the overall growth of the market in developing countries also.

Rapid urbanization and rising disposable income in several countries have propelled a large population to adopt animals. In recent times, the overall costs spent to pamper pets have significantly increased. The necessity of emotional support and growing concern towards pets and animals has increased due to social media and other factors.

Restraints:

The increasing trend of veganism and shifts towards vegetarianism are considered as major restraining factors for the animal health market growth. Increasing health concerns related to improper diet and high-fat diet have propelled a huge population to adopt a vegetarian diet across the globe. Such factors are considered to be the primary growth restricting factor for the market.

The storage and handling of vaccinations for the animals require standards and difficult measures; the inappropriate transportation of the vaccines might make them ineffective and might lead to vaccination failure. The temperature control throughout the transportation up until the end-user is essential. The non-potency of the vaccination can’t be identified by the buyers. Such factors are impacting the growth of the Animal health market adversely.

Challenges:

The inappropriate usage of parasites and antibodies in animals might create resistance to the medication. Lack of awareness in taking care of the cattle and pets is the major reason for the improper dosage of parasiticides and antibodies. 

Lack of data available concerning the diseases of livestock or pet animals and lack of researches concerning the diseases that animals could acquire is considered as the major challenge in the Animal health market. On the other hand, lack of funding in the market when compared to human diseases has also limited the overall growth of the animal health market.

Cumulative growth analysis:

While considering the health care service concerning animals, Vaccines are holding the highest market share in the Animal health market. The parasiticides which come in two forms, which are ectoparasiticides, and endoparasiticides are effective in treating the parasites outside and inside the animal bodies. Dimpylate and trichlorfon were the active ingredients widely used in the industry. The rising developments in organochlorines, organophosphates, carbamates, amidines, synthetic pyrethroids are stimulating the overall growth of the market. These active ingredients are efficient in controlling the parasites and other veterinary parasites.

The increasing pet ownership in several countries is also presenting lucrative opportunities for the animal health market growth. The increasing consumption of red meat and dairy products across the globe is also stimulating the overall growth of the market.

Value chain analysis:

The food-producing animals are expected to hold the largest animal health market share in the forecast period, owing to the increasing consumption of dairy products and red meats. India is considered the leading producer and consumer of milk products, and meat. Over 3.2 million metric tons of meat were consumed in the year 2020. Such factors are increasing the overall market growth globally. On the other hand, countries such as America, Europe are concerned about consuming fresh meat, the advent of temperature tags and other novel technologies ensure that their meat produce is fresh and healthy.

The health concerns and awareness are increasing in the developed countries, which propel them to acquire necessary information about the food they consume. On the other hand, the increasing demand for pet ownership in the countries such as China, India, and other Asia-pacific countries has stimulated the Animal health market growth. Increasing disposable incomes and favorable economic conditions in countries like China, and other developed countries, have prepared a huge population in spending on their pets and other health care services related to their pets. 

A recent study by the US meat Export federation has stated that China is leading in pork consumption, the study shows that the consumption had grown from 29 kilograms per person in the year 2012 to 35 kilograms in the year 2019. 

Animal Health Market Segmentation

 Animal Health Vaccines Outlook

Live Attenuated Vaccines Inactivated Vaccines Toxoid Vaccines Other Vaccines

Animal Health Feed Additives Outlook

Amino Acids Binders Vitamins Minerals Feed Acidifiers Other Feed Additives

 Animal Health Growth Promoter Outlook

Acidifiers Hormonal Growth promoters Prebiotics & Probiotics Feed Enzymes Phytogenics Other Growth Promoters Other Pharmaceuticals

Animal Health Animal Type Outlook

Food-Producing Animals Cattle Pigs Poultry Sheep & Goats Other Food-Producing Animals Companion Animals Cats Dogs Horses Other Companion Animals

Animal Health End-User Outlook

Veterinary Hospitals & Clinics Animal Farms Homecare.

Regional analysis

Europe has significantly influenced other non-European countries by their high standards in protecting farm animals, fisheries, domestic animals, and cattle. Their standards were primarily regarding slaughtering and transporting them to the other areas. On the other hand, they have generic standards for protecting wildlife and laboratory animals as well. In the year 2018, the country has adopted a novel regulation called MEPs which is to obtain several medications available in the market to upgrade the overall health of the cattle and to increase their production.

A recent survey has stated that the European veterinary segment is expected to witness steady growth in the forecast period and project a CAGR of 3.2% by the year 2032. The demand for the meat products in the region propels testing them for food-borne diseases; this factor is considered as a primary growth-stimulating factor.

On the other hand, the Canadian Government has also imposed significant standards in protecting the health of Animals. The government initiatives include educational sessions, which educate the cattle owners about the challenges in the agricultural industry, scientific investigations to clear the potential gaps in animal welfare, an inspection of dairy farms, and checking if they are complying with the regulations concerning the cleanliness, water facility, suitable animal housing and other factors. Such initiatives have increased the overall growth of the animal health market in the region.

The U.S. launch of Animo® GPS, an activity and behavioral monitor for dogs with GPS tracking capabilities, was announced by Merck Animal Health, also known as MSD Animal Health outside of the U.S. and Canada. The product enables real-time tracking with position updates starting every 5 seconds in "Lost Dog Mode" and may notify pet owners in 20 seconds if their dog exits its assigned "Safe Zone." Animo GPS uses sophisticated technology to measure a dog's individual activity levels and behavior within a user-friendly mobile app in addition to its location tracking features.

Data on shaking, barking, scratching, and sleep duration are all recorded by the device. If there are any major changes in these behaviors, it can utilize an adaptive algorithm to analyze this information and issue an alert via the app.

A new checkpoint inhibitor cancer care for dogs has been licensed by Ardent Animal Health, a company in the Breakthru Investment Portfolio. The therapy is intended to catalyze the Ardent pipeline's current lineup of cancer therapies. Canine cancer is thought to occur in 50% of dogs over ten. The human market, witnessing a breakthrough with innovative immunotherapies for various diseases, has lagged in specialized cancer treatments for animals.

Competitive landscape:

Animal health companies in global market are given below

Bayer AG Virbac SA Zoetis, Inc. Hester Biosciences Ltd. Intas Pharmaceuticals Ltd. Merck Animal Health Elanco (Eli Lilly and Company) Ceva Santé Animale Alvira Animal Health Limited Vetoquinol S.A. Boehringer Ingelheim GmbH Zydus Animal Health Norbrook Laboratories Limited Phibro Animal Health Corporation Dechra Pharmaceuticals PLC Norbrook Laboratories, Inc

Animal Health Market Industry Developments

Q2 2024: Zoetis receives FDA approval for Librela, a new osteoarthritis treatment for dogs Zoetis announced that the U.S. Food and Drug Administration approved Librela, its monoclonal antibody therapy for canine osteoarthritis, marking a significant expansion of its animal health portfolio. Q2 2024: Elanco Animal Health completes acquisition of Kindred Biosciences Elanco finalized its acquisition of Kindred Biosciences, strengthening its pipeline in biologics and expanding its companion animal therapeutics offerings. Q3 2024: Merck Animal Health launches new swine vaccine in the U.S. Merck Animal Health introduced a novel vaccine for swine respiratory disease, aiming to address rising concerns over livestock health and productivity. Q3 2024: Boehringer Ingelheim opens new animal vaccine manufacturing facility in France Boehringer Ingelheim inaugurated a state-of-the-art vaccine production plant in Lyon, France, to boost its capacity for veterinary biologics in Europe. Q4 2024: Ceva Santé Animale acquires U.S.-based Artemis Technologies Ceva Santé Animale expanded its North American footprint by acquiring Artemis Technologies, a developer of digital animal health monitoring solutions. Q4 2024: Virbac announces partnership with Chinese distributor for companion animal products Virbac entered a strategic partnership with a leading Chinese distributor to accelerate the rollout of its companion animal health products in China. Q1 2025: Bayer appoints new Head of Animal Health Division Bayer announced the appointment of Dr. Anna Müller as the new global head of its Animal Health Division, effective January 2025. Q1 2025: Phibro Animal Health secures multi-year contract with major U.S. poultry producer Phibro Animal Health signed a multi-year supply agreement to provide nutritional and health products to one of the largest poultry producers in the United States. Q2 2025: Dechra Pharmaceuticals launches new feline diabetes treatment in Europe Dechra Pharmaceuticals introduced a novel oral medication for feline diabetes, expanding its specialty therapeutics portfolio in the European market. Q2 2025: Zoetis announces $200 million investment in new R&D center in Singapore Zoetis revealed plans to build a new research and development facility in Singapore, focusing on next-generation vaccines and biologics for animal health. Q3 2025: Merck Animal Health receives EMA approval for new cattle parasite treatment Merck Animal Health secured European Medicines Agency approval for a new antiparasitic product targeting cattle, enhancing its livestock health portfolio. Q3 2025: Elanco Animal Health announces partnership with Israeli biotech startup for novel pet therapeutics Elanco entered a collaboration with an Israeli biotech firm to co-develop innovative therapeutics for companion animals, focusing on chronic disease management.

Report Overview

This report has covered:

Market overview COVID 19 Analysis Market dynamics Cumulative growth analysis Value chain analysis Segment overview Regional analysis Competitive landscape Recent developments

The rise in pet ownership globally is significantly influencing the Global Animal Health Market Industry. As more households adopt pets, there is a growing emphasis on preventive healthcare and wellness for companion animals. This trend is evident in the increasing expenditure on veterinary services, vaccinations, and pet medications. The market is expected to benefit from this shift, as pet owners prioritize the health and well-being of their animals. Consequently, the demand for high-quality animal health products and services is likely to rise, further propelling market growth.

The Global Animal Health Market Industry is poised for substantial growth, with projections indicating a market size of 68.5 USD Billion in 2024 and an anticipated increase to 161.9 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 8.13% from 2025 to 2035, highlighting the increasing importance of animal health in global food systems. The market is expected to expand as stakeholders recognize the critical role of animal health in ensuring food security and public health, driving investments in innovative health solutions and technologies.

Sustainability is becoming a central theme in the Global Animal Health Market Industry. Stakeholders are increasingly recognizing the importance of sustainable farming practices and animal welfare. This shift is driven by consumer preferences for ethically sourced animal products and the need to address environmental concerns. As a result, companies are investing in sustainable health solutions, such as organic feed and environmentally friendly veterinary products. This focus on sustainability not only enhances brand reputation but also aligns with global efforts to promote responsible animal husbandry, thereby fostering market growth.

Regulatory frameworks and standards play a crucial role in shaping the Global Animal Health Market Industry. Governments worldwide are implementing stringent regulations to ensure animal welfare and food safety. This regulatory support encourages the adoption of best practices in animal health management. For example, the establishment of guidelines for antibiotic use in livestock aims to combat antimicrobial resistance, thereby promoting healthier animal populations. Such regulations not only enhance public health but also stimulate market growth by fostering innovation and compliance among animal health companies.

The increasing global population and the subsequent rise in demand for animal protein are pivotal drivers of the Global Animal Health Market Industry. As consumers become more health-conscious, the demand for high-quality meat, dairy, and eggs is expected to surge. This trend is reflected in the projected market size, which is anticipated to reach 68.5 USD Billion in 2024 and grow significantly to 161.9 USD Billion by 2035. The compound annual growth rate of 8.13% from 2025 to 2035 indicates a robust market expansion, necessitating enhanced animal health measures to ensure food safety and quality.

Technological advancements in veterinary medicine are transforming the Global Animal Health Market Industry. Innovations such as telemedicine, advanced diagnostics, and biotechnology are enhancing the ability to treat and prevent diseases in animals. For instance, the development of vaccines and therapeutics tailored for specific animal species has improved health outcomes and reduced mortality rates. As these technologies become more accessible, they are likely to drive market growth, as veterinarians and animal owners increasingly adopt these solutions to maintain animal health and productivity.